ACHC Form 4: CFO awarded 48,445 shares, vest over 3 years

Rhea-AI Filing Summary

Acadia Healthcare (ACHC) reported an insider equity award for its Chief Financial Officer, Todd S. Young. On 10/27/2025, he acquired 48,445 shares of common stock at $0.00 per share. According to the filing, these shares will vest over three years in equal annual installments beginning 10/27/2026. Following this transaction, Young beneficially owned 48,445 shares, held directly.

Insider Trade Summary

Net Buyer: 48,445 shares

Net Buy 1 txn

Insider YOUNG TODD S.

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	48,445	$0.00	$0.00

Holdings After Transaction: Common Stock — 48,445 shares (Direct)

Footnotes (1)

1. F1. Shares will vest over a 3-year period in equal yearly installments beginning October 27, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 10/28/2025 - 05:42 PM Learn about SEC filing dates

FAQ

What insider transaction did ACHC disclose on Form 4?

The CFO, Todd S. Young, acquired 48,445 shares of common stock at $0.00 on 10/27/2025.

What is the vesting schedule for the ACHC CFO’s shares?

The shares will vest in equal yearly installments over 3 years beginning 10/27/2026.

How many ACHC shares does the CFO own after the transaction?

Following the transaction, the CFO beneficially owned 48,445 shares.

What is the ownership form of the ACHC CFO’s holdings?

The filing lists the ownership form as Direct (D).

Who signed the ACHC Form 4 and when?

It was signed by /s/ Brian Farley as Attorney-in-Fact for Todd S. Young on 10/28/2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

YOUNG TODD S.

(Last) (First) (Middle)

6100 TOWER CIRCLE, SUITE 1000

(Street)

FRANKLIN TN 37067

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Acadia Healthcare Company, Inc. [ ACHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/27/2025		A		48,445(1)	A	$0.00	48,445	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares will vest over a 3-year period in equal yearly installments beginning October 27, 2026.

	/s/ Brian Farley as Attorney in Fact for Todd S. Young	10/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.